Ravirala D - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy.

Ravirala D, Mistretta B, Gunaratne PH, Pei G, Zhao Z, Zhang X. Ravirala D, et al. J Immunother Cancer. 2021 Jul;9(7):e002454. doi: 10.1136/jitc-2021-002454. J Immunother Cancer. 2021. PMID: 34230110 Free PMC article.

Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing.

Ravirala D, Pei G, Zhao Z, Zhang X. Ravirala D, et al. Cancer Immunol Immunother. 2022 Jun;71(6):1479-1495. doi: 10.1007/s00262-021-03084-2. Epub 2021 Oct 30. Cancer Immunol Immunother. 2022. PMID: 34716463 Free PMC article.

Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue.

Ravirala D, Pei G, Zhao Z, Zhang X. Ravirala D, et al. Mol Ther Oncolytics. 2021 Oct 20;23:330-341. doi: 10.1016/j.omto.2021.10.006. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34786476 Free PMC article.

Current strategies in engaging oncolytic viruses with antitumor immunity.

Boagni DA, Ravirala D, Zhang SX. Boagni DA, et al. Among authors: ravirala d. Mol Ther Oncolytics. 2021 May 14;22:98-113. doi: 10.1016/j.omto.2021.05.002. eCollection 2021 Sep 24. Mol Ther Oncolytics. 2021. PMID: 34514092 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters